NEUROPROTECTION WITH GLUTAMATE AND ARNICA MONTANA
NEUROPROTECTION WITH GLUTAMATE AND ARNICA MONTANA
批准号:
6083988
负责人:
WAYNE B JONAS
金额:
$29.05万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2003-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Diseases of neurodegeneration and brain damage from non-missile
head trauma account for nearly 500,000 hospital admissions in the U.S.
annually. Although the etiology may differ, the same anatomic and physiologic
substrates are involved in these conditions, including ischemia and hypoxic
injury and the release of excitatory amino acids, especially glutamate from
diseased or damaged cells. We have been using in vitro and in vivo models of
experimental ischemia and cellular models of glutamate toxicity to examine
these mechanisms of neuronal injury, and to target early intervention treatment
strategies for neurodegeneration.
One promising strategy that has not been explored is the use of low doses of
chemicals to enhance cell tolerance and recovery. High doses of toxic chemicals
will inhibit and kill biological systems, while low doses frequently stimulate
those systems. Stimulation of cell function by exposure to low doses of
chemicals can often mitigate the adverse effects produced by high doses. This
phenomenon is the theoretical basis for the observed effects in homeopathy.
While paradoxical dose effects been demonstrated across multiple cells types
and phyla they have not yet been examined in neurodegeneration. In preliminary
research we have demonstrated that protective effects occur in neuronal cells
exposed to low and ultra-low doses of glutamate and that ultra-low dose
glutamate and homeopathic Arnica montana can significantly reduce brain damage
from ischemia in vivo.
The objective of this project is to use neuronal culture systems and ischemia
models of brain injury to identify the optimal protective doses and routes of
glutamate and homeopathic Arnica montana exposure. Once these dosages are
identified we will examine the in vivo effects of these preparations to target
mechanism and clinical studies in the future. We will have developed, for the
first time, a systematic model for the scientific study of protective hormesis
and homeopathy in neurodegeneration and brain injury.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/1472-6882-1-12
发表时间:
2001-01-01
期刊:
BMC complementary and alternative medicine
影响因子:
--
作者:
[Jonas, W B, Anderson, R L, Lyons, J S]
通讯作者:
Lyons, J S
Non-linear effects of cycloheximide in glutamate-treated cultured rat cerebellar neurons.
放线菌酮对谷氨酸处理的培养大鼠小脑神经元的非线性影响。
DOI:
10.1016/s0161-813x(02)00058-x
发表时间:
2002
期刊:
Neurotoxicology
影响因子:
3.4
作者:
[Marotta,Diane, Marini,Ann, Banaudha,Krishna, Maharaj,Susan, Ives,John, Morrissette,CraigR, Jonas,WayneB]
通讯作者:
Jonas,WayneB
Complex Isopathic Drug Development for Neuroprotection
-
批准号:6431273
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2002
-
负责人:WAYNE B JONAS
-
依托单位:
Complex Isopathic Drug Development for Neuroprotection
-
批准号:6621275
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2002
-
负责人:WAYNE B JONAS
-
依托单位:
EFFECTS OF LOW-DOSE CADMIUM ON PROSTATE CELLS
-
批准号:6164041
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2000
-
负责人:WAYNE B JONAS
-
依托单位: